Top 10 Books about Stock Investing to read in 2018. Read more.

SRNE - Sorrento Therapeutics

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

SRNE - Sorrento Therapeutics

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

Tue 06'th Mar 2018

PERIOD 2017-12-07 - 2018-03-06
CHANGE 6.57%
PRICE $7.30






Sorrento Therapeutics Stock Analysis

Technical stock analysis for Tue 06'th Mar 2018

Sell candidate since 2018-03-02 Gain 1.39%

Sorrento Therapeutics gained 6.57% in the last trading day, rising from $6.85 to $7.30 The price has fallen in 6 of the last 10 days and is down by -17.05% for this period. Volume fell in the last day by -1.74 million shares, and in total, 3.62 million shares bought and sold for approximately $26.39 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Shorts 1.19% ( 2018-02-15 )
Cash 212.2 mill
Loans 126.9 mill
Beta 2.48
ROA -5.45


Sorrento Therapeutics lies in the lower part of a very wide and strong rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $6.97 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 173.28% during the next 3 months and, with 90% probability hold a price between $19.04 and $29.52 at the end of this period.

Click here for today's Top 5 Trending Companies


A buy signal was issued from a pivot bottom point on Monday March 05, 2018, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. Sorrento Therapeutics holds sales signals from both short- and long-term moving averages. On corrections up there will be some resistance from the lines at $8.02 and $7.64. A break-up above any of these levels will issue buy signals.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 50 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Sorrento Therapeutics finds support from accumulated volume at $7.25. On the upside the stock meets some resistance just above today's level from accumulated volume at $7.55, $7.75 and $9.05.

The stock is about to test the resistance from accumulated volume at $7.55 and this may cause the stock to take a minor break or get into a more sideways move for a few days.

Support: $7.25 Price: $7.30 Resistance: $7.55


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.64 between high and low, or 9.40%. For the last week, the stock has had a daily average volatility of 19.69%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High


The Sorrento Therapeutics stock holds several negative signals and despite the positive trend we believe Sorrento Therapeutics will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Trade SRNE CFDs with Plus500

Your capital is at risk.

Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).